PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32733956-9	2020	Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 via inhibiting p38MAPK phosphorylation.	coomassie Brilliant Blue	25-41	interleukin 1 beta	Rattus norvegicus	156-173	
32733956-9	2020	Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 via inhibiting p38MAPK phosphorylation.	coomassie Brilliant Blue	43-46	interleukin 1 beta	Rattus norvegicus	156-173	
15965498-4	2005	The increase in plasma concentrations of IL-1beta and IL-6, measured 1 h after LPS treatment, was reduced by PPADS (25 mg kg(-1)) and BBG (100 mg kg(-1)).	coomassie Brilliant Blue	134-137	interleukin 1 beta	Rattus norvegicus	41-49	
30570747-8	2019	The microinjection of the P2X7R antagonist brilliant blue G (BBG, a non-competitive P2X7R antagonist) into the RVM prevented the development of mechanical allodynia, inhibited the activation of microglia, and decreased the expression of IL-1beta and 8-hydroxyguanine in the RVM following SMIR.	coomassie Brilliant Blue	43-59	interleukin 1 beta	Rattus norvegicus	237-245	
30570747-8	2019	The microinjection of the P2X7R antagonist brilliant blue G (BBG, a non-competitive P2X7R antagonist) into the RVM prevented the development of mechanical allodynia, inhibited the activation of microglia, and decreased the expression of IL-1beta and 8-hydroxyguanine in the RVM following SMIR.	coomassie Brilliant Blue	61-64	interleukin 1 beta	Rattus norvegicus	237-245	
25873133-10	2015	Following trauma, BBG treatment significantly reduced the levels of PKCgamma and interleukin-1beta in the cortex.	coomassie Brilliant Blue	18-21	interleukin 1 beta	Rattus norvegicus	81-98	
25873133-11	2015	The results provide in vivo evidence that BBG exerted neuroprotective effects by attenuating brain edema and improving neurological functions via reducing PKCgamma and interleukin-1beta levels following TBI.	coomassie Brilliant Blue	42-45	interleukin 1 beta	Rattus norvegicus	168-185	
25933224-6	2015	BBG also ameliorated liver fibrosis and down-regulated hepatic interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), PDGF, IL-1beta, transforming growth factor-beta (TGF-beta), p-extracellular-signal-regulated kinases (ERK), and alpha-smooth muscle actin (alpha-SMA) expressions in CBDL rats.	coomassie Brilliant Blue	0-3	interleukin 1 beta	Rattus norvegicus	132-140